vs

Side-by-side financial comparison of Quanterix Corp (QTRX) and 10x Genomics, Inc. (TXG). Click either name above to swap in a different company.

Quanterix Corp is a life sciences firm that develops, manufactures, and commercializes ultra-sensitive single-molecule detection diagnostic platforms, reagents, and testing services. Its solutions empower biological research, drug development, and clinical diagnostics across oncology, neurodegenerative disorders, infectious diseases, and other therapeutic areas, serving research institutions, biopharmaceutical companies, and clinical laboratories globally.

10x Genomics, Inc. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
QTRX
QTRX
TXG
TXG
Q4 25
$43.9M
Q3 25
$40.2M
Q2 25
$24.5M
Q1 25
$30.3M
Q4 24
$35.2M
Q3 24
$35.8M
Q2 24
$34.4M
Q1 24
$32.1M
Net Profit
QTRX
QTRX
TXG
TXG
Q4 25
$-23.1M
Q3 25
$-33.5M
Q2 25
$-30.0M
Q1 25
$-20.5M
Q4 24
$-11.6M
Q3 24
$-8.4M
Q2 24
$-7.4M
Q1 24
$-11.2M
Gross Margin
QTRX
QTRX
TXG
TXG
Q4 25
45.7%
Q3 25
42.8%
Q2 25
46.2%
Q1 25
54.1%
Q4 24
63.0%
Q3 24
56.3%
Q2 24
64.7%
Q1 24
57.8%
Operating Margin
QTRX
QTRX
TXG
TXG
Q4 25
-56.4%
Q3 25
-92.8%
Q2 25
-151.6%
Q1 25
-86.9%
Q4 24
-42.0%
Q3 24
-32.8%
Q2 24
-31.8%
Q1 24
-47.3%
Net Margin
QTRX
QTRX
TXG
TXG
Q4 25
-52.7%
Q3 25
-83.3%
Q2 25
-122.6%
Q1 25
-67.6%
Q4 24
-33.1%
Q3 24
-23.3%
Q2 24
-21.5%
Q1 24
-34.8%
EPS (diluted)
QTRX
QTRX
TXG
TXG
Q4 25
$-0.48
Q3 25
$-0.73
Q2 25
$-0.77
Q1 25
$-0.53
Q4 24
$-0.30
Q3 24
$-0.22
Q2 24
$-0.19
Q1 24
$-0.29

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons